Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18
Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA
Monrovia, CA, March 08, 2008 --(PR.com)-- Senator Richard Moore will speak on April 18, 2008 on recent stem cell legislation and policy initiatives at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics in Boston, MA.
Senator Richard Moore who is chairman of the Joint Committee on Health Care Financing is actively involved in current stem cell legislation to reverse restrictions on stem cell research. The research limits, drafted by Governor Mitt Romney's aides and adopted by the state Public Health Council, generated widespread criticism from scientists and leading legislators.
Senator Moore will highlight some of the key stem cell issues the state will face in 2008 and in the coming years, including the announcement of Massachusetts’ $1 billion stem cell plan. The money would go to support research and enhancing the work being done at public universities in the state, as well as the creation of a stem cell bank and a repository of stem cell lines that could be used by researchers all over the world.
The 4th international conference brings together leading stem cell experts to discuss new and unreleased information on the latest cutting-edge advancements in the field including the differentiation of Stem Cells, epigenomics & reprogramming, imaging, cancer stem cells, applications in drug discovery, regulatory aspects and funding opportunities. Among the keynote presenters is Dr. Rudolf Jaenisch, the founding member of the Whitehead Institute and Professor of Biology at MIT speaking on “Stem Cells, Pluripotency and Nuclear Reprogramming.” Other presenting organizations include Merck, FDA, Genzyme, Geron, Harvard, Applied Biosystems, Athersys, Cellartis, Pfizer, Novocell, Sanofi-Aventis, Plasticell, Stemagen and more! Visit www.gtcbio.com or call 626-256-6405 for more information.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Senator Richard Moore who is chairman of the Joint Committee on Health Care Financing is actively involved in current stem cell legislation to reverse restrictions on stem cell research. The research limits, drafted by Governor Mitt Romney's aides and adopted by the state Public Health Council, generated widespread criticism from scientists and leading legislators.
Senator Moore will highlight some of the key stem cell issues the state will face in 2008 and in the coming years, including the announcement of Massachusetts’ $1 billion stem cell plan. The money would go to support research and enhancing the work being done at public universities in the state, as well as the creation of a stem cell bank and a repository of stem cell lines that could be used by researchers all over the world.
The 4th international conference brings together leading stem cell experts to discuss new and unreleased information on the latest cutting-edge advancements in the field including the differentiation of Stem Cells, epigenomics & reprogramming, imaging, cancer stem cells, applications in drug discovery, regulatory aspects and funding opportunities. Among the keynote presenters is Dr. Rudolf Jaenisch, the founding member of the Whitehead Institute and Professor of Biology at MIT speaking on “Stem Cells, Pluripotency and Nuclear Reprogramming.” Other presenting organizations include Merck, FDA, Genzyme, Geron, Harvard, Applied Biosystems, Athersys, Cellartis, Pfizer, Novocell, Sanofi-Aventis, Plasticell, Stemagen and more! Visit www.gtcbio.com or call 626-256-6405 for more information.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Contact
GTCbio
Rania Hafez
626-256-6405
http://www.gtcbio.com
Rania Hafez
626-256-6405
http://www.gtcbio.com
Contact
Categories